Literature DB >> 30293968

Spatial Distribution of Endogenous Tissue Protease Activity in Gastric Carcinoma Mapped by MALDI Mass Spectrometry Imaging.

Katrin Erich1, Kevin Reinle2, Torsten Müller3, Bogdan Munteanu2, Denis A Sammour1, Isabel Hinsenkamp4, Tobias Gutting4, Elke Burgermeister4, Peter Findeisen5, Matthias P Ebert4, Jeroen Krijgsveld3, Carsten Hopf6.   

Abstract

Aberrant protease activity has been implicated in the etiology of various prevalent diseases including neurodegeneration and cancer, in particular metastasis. Matrix-assisted laser desorption/ionization (MALDI) mass spectrometry imaging (MSI) has recently been established as a key technology for bioanalysis of multiple biomolecular classes such as proteins, lipids, and glycans. However, it has not yet been systematically explored for investigation of a tissue's endogenous protease activity. In this study, we demonstrate that different tissues, spray-coated with substance P as a tracer, digest this peptide with different time-course profiles. Furthermore, we reveal that distinct cleavage products originating from substance P are generated transiently and that proteolysis can be attenuated by protease inhibitors in a concentration-dependent manner. To show the translational potential of the method, we analyzed protease activity of gastric carcinoma in mice. Our MSI and quantitative proteomics results reveal differential distribution of protease activity - with strongest activity being observed in mouse tumor tissue, suggesting the general applicability of the workflow in animal pharmacology and clinical studies.
© 2019 Erich et al.

Entities:  

Keywords:  Cancer Biology; Gastrointestinal Disease; Imaging; MALDI Imaging; MALDI Mass Spectrometry; Mass Spectrometry; Mass Spectrometry Imaging; Protease Activity; Proteases

Mesh:

Substances:

Year:  2018        PMID: 30293968      PMCID: PMC6317471          DOI: 10.1074/mcp.RA118.000980

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  39 in total

Review 1.  Enzyme activity--it's all about image.

Authors:  Amos Baruch; Douglas A Jeffery; Matthew Bogyo
Journal:  Trends Cell Biol       Date:  2004-01       Impact factor: 20.808

2.  From whole-body sections down to cellular level, multiscale imaging of phospholipids by MALDI mass spectrometry.

Authors:  Pierre Chaurand; Dale S Cornett; Peggi M Angel; Richard M Caprioli
Journal:  Mol Cell Proteomics       Date:  2010-08-23       Impact factor: 5.911

3.  Impact of temperature dependent sampling procedures in proteomics and peptidomics--a characterization of the liver and pancreas post mortem degradome.

Authors:  Birger Scholz; Karl Sköld; Kim Kultima; Celine Fernandez; Sofia Waldemarson; Mikhail M Savitski; Marcus Söderquist; Mats Borén; Robert Stella; Per Andrén; Roman Zubarev; Peter James
Journal:  Mol Cell Proteomics       Date:  2010-01-28       Impact factor: 5.911

4.  Molecular imaging in cancer.

Authors:  Ralph Weissleder
Journal:  Science       Date:  2006-05-26       Impact factor: 47.728

5.  MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification.

Authors:  Jürgen Cox; Matthias Mann
Journal:  Nat Biotechnol       Date:  2008-11-30       Impact factor: 54.908

6.  Classification of HER2/neu status in gastric cancer using a breast-cancer derived proteome classifier.

Authors:  Benjamin Balluff; Mareike Elsner; Andreas Kowarsch; Sandra Rauser; Stephan Meding; Christoph Schuhmacher; Marcus Feith; Ken Herrmann; Christoph Röcken; Roland M Schmid; Heinz Höfler; Axel Walch; Matthias P Ebert
Journal:  J Proteome Res       Date:  2010-11-08       Impact factor: 4.466

Review 7.  Emerging principles in protease-based drug discovery.

Authors:  Marcin Drag; Guy S Salvesen
Journal:  Nat Rev Drug Discov       Date:  2010-09       Impact factor: 84.694

8.  mMass 3: a cross-platform software environment for precise analysis of mass spectrometric data.

Authors:  Martin Strohalm; Daniel Kavan; Petr Novák; Michael Volný; Vladimír Havlícek
Journal:  Anal Chem       Date:  2010-06-01       Impact factor: 6.986

9.  A transgenic mouse line that develops early-onset invasive gastric carcinoma provides a model for carcinoembryonic antigen-targeted tumor therapy.

Authors:  J Thompson; T Epting; G Schwarzkopf; A Singhofen; A M Eades-Perner; H van Der Putten; W Zimmermann
Journal:  Int J Cancer       Date:  2000-06-15       Impact factor: 7.396

10.  Sigma's Non-specific Protease Activity Assay - Casein as a Substrate.

Authors:  Carrie Cupp-Enyard
Journal:  J Vis Exp       Date:  2008-09-17       Impact factor: 1.355

View more
  4 in total

Review 1.  ADVANCES IN HIGH-RESOLUTION MALDI MASS SPECTROMETRY FOR NEUROBIOLOGY.

Authors:  Kellen DeLaney; Ashley Phetsanthad; Lingjun Li
Journal:  Mass Spectrom Rev       Date:  2020-11-09       Impact factor: 10.946

2.  Automated sample preparation with SP3 for low-input clinical proteomics.

Authors:  Torsten Müller; Mathias Kalxdorf; Rémi Longuespée; Daniel N Kazdal; Albrecht Stenzinger; Jeroen Krijgsveld
Journal:  Mol Syst Biol       Date:  2020-01       Impact factor: 11.429

3.  Label-Free Semiquantitative Liquid Chromatography-Tandem Mass Spectrometry Proteomics Analysis of Laryngeal/Hypopharyngeal Squamous Cell Carcinoma on Formalin-Fixed, Paraffin-Embedded Tissue Samples - a Pilot Study.

Authors:  Andras Burian; Laszlo Lujber; Imre Gerlinger; Tamas Jarai; Eva Orosz; Lilla Turiak; Andras Acs; Zoltan Hegedus; Aniko Konigne Peter; Tamas Tornoczki; Katalin Gombos; Laszlo Mark
Journal:  Pathol Oncol Res       Date:  2020-06-21       Impact factor: 3.201

4.  Multiplex enzyme activity imaging by MALDI-IMS of substrate library conversions.

Authors:  Oliver Klein; Akvile Haeckel; Ulf Reimer; Grit Nebrich; Eyk Schellenberger
Journal:  Sci Rep       Date:  2020-09-23       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.